Ustar Biotechnology Plans Zimbabwe Expansion
The Hangzhou-based firm is seeking to grow its medical diagnostic footprint in Zimbabwe following a leadership tour.
Updated on Oct. 15, 2026 in Healthcare
Live Poll
Do you believe international corporate partnerships help improve the quality of healthcare in your community?
Hangzhou Ustar Biotechnology Company has announced intentions to expand its diagnostic operations in Zimbabwe. This move follows a recent visit by Zimbabwean healthcare professionals to the company's headquarters in Hangzhou.
Why it matters
Expanding these diagnostic capabilities helps address the ongoing issue of infectious diseases in Zimbabwe. The company aims to build on its existing partnerships to strengthen local healthcare infrastructure.
Ustar Biotechnology Company has already supplied 94 pieces of molecular diagnostic equipment to 67 hospitals across Zimbabwe. The firm maintains a local team of medical hardware engineers to support these units.
The players
Ustar Biotechnology Company
This Hangzhou-based medical firm specializes in molecular diagnostic technology and global hardware distribution.
Ministry of Health and Child Care
This Zimbabwean government agency oversees the distribution of medical equipment and national public health initiatives.
Satewave Technologies
This company acts as the local distribution partner for Ustar Biotechnology products in the Zimbabwean market.
The details
Working alongside the Ministry of Health and Child Care and distributor Satewave Technologies, the company utilizes Cross-Priming Isothermal Amplification technology to identify TB cases. The firm previously utilized these testing kits in national vaccine effectiveness studies conducted across six Zimbabwean provinces.
Timeline
Ustar Biotechnology Company was founded in 2005.
The firm first established operations in Zimbabwe in 2019.
A delegation toured the company headquarters on October 15, 2026.
Market Landscape
This move marks a continued shift toward localized molecular diagnostics that compete with traditional laboratory-based testing models. The company seeks to solidify its position against international diagnostic rivals by deepening its integration with local infrastructure.
Healthcare providers in Zimbabwe may gain access to faster and more reliable infectious disease screening tools as the company grows its local presence. Patients could see improved diagnostic accuracy for tuberculosis and other local health threats.
The takeaway
The expansion signals a commitment to strengthening point-of-care diagnostics in regions where infectious diseases present persistent public health challenges. Utilizing localized hardware support can help ensure that medical equipment remains operational over the long term.
Further reading
Learn more about the latest developments in Healthcare.
Source note: This article includes information reported by Herald.
Live Poll
Do you believe international corporate partnerships help improve the quality of healthcare in your community?
